Herrington D - Search Results

1

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Hulley S, et al. Among authors: herrington d. JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605. JAMA. 1998. PMID: 9718051 Clinical Trial.

2

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.

Herrington DM, Braden GA, Williams JK, Morgan TM. Herrington DM, et al. Am J Cardiol. 1994 May 15;73(13):951-2. doi: 10.1016/0002-9149(94)90136-8. Am J Cardiol. 1994. PMID: 8184850 No abstract available.

3

Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.

Schrott HG, Bittner V, Vittinghoff E, Herrington DM, Hulley S. Schrott HG, et al. Among authors: herrington dm. JAMA. 1997 Apr 23-30;277(16):1281-6. JAMA. 1997. PMID: 9109465

4

Estrogen and heart disease: trials to prevent tribulations.

Herrington DM. Herrington DM. Maturitas. 1997 Jul;27(3):199-202. doi: 10.1016/s0378-5122(97)00032-7. Maturitas. 1997. PMID: 9288691 No abstract available.

5

Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III).

Herrington DM, Fong J, Sempos CT, Black DM, Schrott HG, Rautaharju P, Bachorik PS, Blumenthal R, Khan S, Wenger NK. Herrington DM, et al. Am Heart J. 1998 Jul;136(1):115-24. doi: 10.1016/s0002-8703(98)70191-7. Am Heart J. 1998. PMID: 9665228 Clinical Trial.

6

Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.

Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM. Herrington DM, et al. J Am Coll Cardiol. 1999 Jun;33(7):2030-7. doi: 10.1016/s0735-1097(99)00128-x. J Am Coll Cardiol. 1999. PMID: 10362210 Free article. Clinical Trial.

7

The HERS trial results: paradigms lost? Heart and Estrogen/progestin Replacement Study.

Herrington DM. Herrington DM. Ann Intern Med. 1999 Sep 21;131(6):463-6. doi: 10.7326/0003-4819-131-6-199909210-00012. Ann Intern Med. 1999. PMID: 10498564

8

The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain?

Wells G, Herrington DM. Wells G, et al. Among authors: herrington dm. Drugs Aging. 1999 Dec;15(6):419-22. doi: 10.2165/00002512-199915060-00001. Drugs Aging. 1999. PMID: 10641952 Review.

9

Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.

Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S. Grady D, et al. Among authors: herrington d. Ann Intern Med. 2000 May 2;132(9):689-96. doi: 10.7326/0003-4819-132-9-200005020-00002. Ann Intern Med. 2000. PMID: 10787361 Clinical Trial.

10

The estrogen replacement and atherosclerosis (ERA) study: study design and baseline characteristics of the cohort.

Herrington DM, Reboussin DM, Klein KP, Sharp PC, Shumaker SA, Snyder TE, Geisinger KR. Herrington DM, et al. Control Clin Trials. 2000 Jun;21(3):257-85. doi: 10.1016/s0197-2456(00)00054-4. Control Clin Trials. 2000. PMID: 10822123 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results